278 related articles for article (PubMed ID: 21396369)
1. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson PJ; Guicciardi ME; Burton D; McKinzie S; Rao AS; Zinsmeister AR; Gores GJ
Gastroenterology; 2011 Jun; 140(7):1934-42. PubMed ID: 21396369
[TBL] [Abstract][Full Text] [Related]
2. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.
Camilleri M; Klee EW; Shin A; Carlson P; Li Y; Grover M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G13-26. PubMed ID: 24200957
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson PJ; Odunsi-Shiyanbade S; McKinzie S; Busciglio I; Burton D; Zinsmeister AR
Dig Dis Sci; 2012 May; 57(5):1222-6. PubMed ID: 22271411
[TBL] [Abstract][Full Text] [Related]
4. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
[TBL] [Abstract][Full Text] [Related]
6. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
[TBL] [Abstract][Full Text] [Related]
7. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.
Camilleri M; Vazquez-Roque MI; Carlson P; Burton D; Wong BS; Zinsmeister AR
Neurogastroenterol Motil; 2011 Nov; 23(11):995-9, e458. PubMed ID: 21883702
[TBL] [Abstract][Full Text] [Related]
8. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
Rao AS; Wong BS; Camilleri M; Odunsi-Shiyanbade ST; McKinzie S; Ryks M; Burton D; Carlson P; Lamsam J; Singh R; Zinsmeister AR
Gastroenterology; 2010 Nov; 139(5):1549-58, 1558.e1. PubMed ID: 20691689
[TBL] [Abstract][Full Text] [Related]
9. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial.
Oduyebo I; Camilleri M; Nelson AD; Khemani D; Nord SL; Busciglio I; Burton D; Rhoten D; Ryks M; Carlson P; Donato L; Lueke A; Kim K; Rossi SJ; Zinsmeister AR
Am J Gastroenterol; 2018 May; 113(5):725-734. PubMed ID: 29717197
[TBL] [Abstract][Full Text] [Related]
10. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
Camilleri M; Carlson P; Acosta A; Busciglio I
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
[TBL] [Abstract][Full Text] [Related]
11. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
[TBL] [Abstract][Full Text] [Related]
12. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome.
Vazquez-Roque MI; Camilleri M; Carlson P; McKinzie S; Murray JA; Brantner TL; Burton DD; Zinsmeister AR
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):481-7. PubMed ID: 21490506
[TBL] [Abstract][Full Text] [Related]
13. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
[TBL] [Abstract][Full Text] [Related]
14. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
[TBL] [Abstract][Full Text] [Related]
15. Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes.
Grasberger H; Chang L; Shih W; Presson AP; Sayuk GS; Newberry RD; Karagiannides I; Pothoulakis C; Mayer E; Merchant JL
Am J Gastroenterol; 2013 Nov; 108(11):1766-74. PubMed ID: 24060757
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome.
Wong BS; Camilleri M; Busciglio I; Carlson P; Szarka LA; Burton D; Zinsmeister AR
Gastroenterology; 2011 Nov; 141(5):1638-47.e1-7. PubMed ID: 21803011
[TBL] [Abstract][Full Text] [Related]
17. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.
Wong BS; Camilleri M; Eckert D; Carlson P; Ryks M; Burton D; Zinsmeister AR
Neurogastroenterol Motil; 2012 Apr; 24(4):358-e169. PubMed ID: 22288893
[TBL] [Abstract][Full Text] [Related]
18. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.
Camilleri M; Kolar GJ; Vazquez-Roque MI; Carlson P; Burton DD; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(5):G553-60. PubMed ID: 23306084
[TBL] [Abstract][Full Text] [Related]
20. β-Klotho gene variation is associated with liver damage in children with NAFLD.
Dongiovanni P; Crudele A; Panera N; Romito I; Meroni M; De Stefanis C; Palma A; Comparcola D; Fracanzani AL; Miele L; Valenti L; Nobili V; Alisi A
J Hepatol; 2020 Mar; 72(3):411-419. PubMed ID: 31655133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
